Ketorolac, a potent nonsteroidal anti-inflammatory drug (NSAID), is primarily utilized for its powerful analgesic and antipyretic effects. While effective for short-term management of moderate to severe pain, its use is accompanied by a distinct set of contraindications that demand careful consideration. Understanding when this medication should be strictly avoided is essential for patient safety and the prevention of severe adverse events. This overview details the specific clinical scenarios where ketorolac is contraindicated.
Absolute Contraindications: Situations Where Ketorolac Must Never Be Used
Certain conditions represent absolute contraindications to ketorolac, meaning the drug must not be administered under any circumstances due to the high risk of life-threatening complications. These contraindications are based on well-established pharmacological risks associated with the NSAID class.
History of Asthma Aggravated by Aspirin or Other NSAIDs
One of the most critical contraindications is a history of asthma, urticaria, or allergic-type reactions after the administration of aspirin or other NSAIDs. This condition, often referred to as aspirin-exacerbated respiratory disease (AERD) or Samter's triad, can lead to severe bronchospasm, airway obstruction, and even fatal anaphylactic reactions upon exposure to ketorolac.
Active Peptic Ulcer Disease or Gastrointestinal Bleeding
Ketorolac significantly inhibits the production of protective prostaglandins in the gastrointestinal tract. Consequently, it is absolutely contraindicated in patients with active peptic ulcer disease, recent gastrointestinal bleeding, or a history of recurrent peptic ulcers. The use of ketorolac in these individuals dramatically increases the risk of serious, potentially life-threatening gastrointestinal erosion and hemorrhage.
Severe Renal Impairment and Post-Operative Renal Failure
As a potent NSAID, ketorolac can induce acute renal vasoconstriction, leading to a significant reduction in glomerular filtration rate. It is contraindicated in patients with severe renal impairment, including those requiring dialysis, and is strictly prohibited for use following coronary artery bypass graft (CABG) surgery due to the unacceptable risk of acute renal failure.
Hypersensitivity and Coagulation Disorders
Individuals with a demonstrated hypersensitivity to ketorolac or any of its excipients should not receive the medication. Additionally, because ketorolac inhibits platelet aggregation and prolongs bleeding time, it is contraindicated in patients with active bleeding or severe coagulation disorders, such as hemophilia.
Relative Contraindications: Situations Requiring Extreme Caution
Beyond absolute contraindications, several relative contraindications necessitate a careful risk-benefit analysis. In these cases, ketorolac may only be considered if the potential benefits outweigh the significant risks, and typically only under strict medical supervision with alternative treatments deemed inappropriate.
Cardiovascular and Hepatic Conditions
Patients with significant cardiovascular disease, including congestive heart failure, hypertension, or a history of myocardial infarction, should use ketorolac with extreme caution. The drug can promote sodium and fluid retention, potentially exacerbating heart failure. Similarly, individuals with moderate to severe hepatic impairment or active liver disease are at increased risk for adverse hepatic events and generally should not receive ketorolac.
Pregnancy and the Elderly
Ketorolac is contraindicated during the third trimester of pregnancy due to the risk of premature closure of the ductus arteriosus in the fetus and potential adverse effects on renal function. In the elderly population, the risk of gastrointestinal bleeding, renal toxicity, and adverse cardiovascular events is substantially elevated, making them particularly vulnerable and requiring the lowest effective dose for the shortest duration possible if use is unavoidable.
